Testosterone flare after initiation of LHRH could theoretically result in symptomatic progression of prostate cancer, though we do not have a high level of evidence to show that this happens, and thus the role of antiandrogens in preventing these side effects is controversial. This evidence concerns the gene GNRH1 and Familial prostate cancer.